<DOC>
	<DOCNO>NCT01345513</DOCNO>
	<brief_summary>This research do find types gene mutation present people cancer . This study design help researcher doctor understand cancer . With information , doctor may better idea cancer treatment appropriate certain patient . The information also help researcher find identify gene cancer biopsy blood sample use information help doctor patient make treatment decision .</brief_summary>
	<brief_title>Feasibility Clinical Study Targeted Genome-Wide Sequencing</brief_title>
	<detailed_description>This prospective cohort study goal obtain fresh tumor biopsy one blood sample patient confirm histological cytological diagnosis cancer , potential candidate phase I II clinical trial local institution . DNA fresh tumor biopsy mononuclear blood cell subject targeted genome-wide sequence enable molecular characterization tumor . Application genomic information investigator capture . Archived tumor sample request patient . For patient malignant ascites pleural effusion , fluid tumor sample evaluate .</detailed_description>
	<criteria>Age &gt; 18 year . Histological cytological proof solid tumour cancer . At least one biopsiable lesion deem medically accessible safe biopsy . Candidate one phase I II clinical trial local institution another Ontario institution , time study enrollment later time point . Fulfills local institution 's laboratory parameter tumor biopsy . Willingness ability patient provide sign voluntary informed consent . Any condition could interfere ability provide inform consent dementia severe cognitive impairment . Any contraindication undergo biopsy procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Genomic Analysis</keyword>
	<keyword>Sequencing</keyword>
	<keyword>Genetic</keyword>
	<keyword>Biopsy</keyword>
	<keyword>Solid tumor</keyword>
</DOC>